Multisystem Involvement in a Pediatric Patient With Suspected Mucopolysaccharidosis: A Case Report
- PMID: 38894766
- PMCID: PMC11184629
- DOI: 10.7759/cureus.60593
Multisystem Involvement in a Pediatric Patient With Suspected Mucopolysaccharidosis: A Case Report
Abstract
Mucopolysaccharidoses (MPS) are a group of inherited metabolic disorders characterized by the deficiency or malfunction of lysosomal enzymes responsible for glycosaminoglycan (GAG) degradation. We present the case of an 11-year-old male with a history of calcified mitral valve, rheumatic heart disease, and growth hormone deficiency who presented with dyspnea on exertion. Physical examination revealed dysmorphic facial features, short stature, and suboptimal weight and height parameters. Magnetic resonance imaging (MRI) of the brain showed cystic lesions in the white matter and corpus callosum, hydrocephalus, and cerebral atrophy, suggestive of MPS. This case highlights the importance of considering MPS in the differential diagnosis of patients with multisystemic involvement and the utility of advanced imaging techniques like MRI in guiding diagnosis and management. A multidisciplinary approach involving cardiology, endocrinology, genetics, and neurology is crucial for comprehensive management and improving patient outcomes. Early diagnosis and intervention are essential in optimizing the quality of life for patients with MPS.
Keywords: growth hormone deficiency; metabolic disorder; mri; mucopolysaccharidoses; multisystem involvement; pediatric patient.
Copyright © 2024, Sachani et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures





Similar articles
-
Left-sided valvular heart disease and retinopathy in a 38-year-old woman with attenuated mucopolysaccharidosis: a case report.Ther Adv Rare Dis. 2023 Jan 12;4:26330040221145945. doi: 10.1177/26330040221145945. eCollection 2023 Jan-Dec. Ther Adv Rare Dis. 2023. PMID: 37181073 Free PMC article.
-
Longitudinal MRI brain volume changes over one year in children with mucopolysaccharidosis types IIIA and IIIB.Mol Genet Metab. 2021 Jun;133(2):193-200. doi: 10.1016/j.ymgme.2021.04.006. Epub 2021 Apr 27. Mol Genet Metab. 2021. PMID: 33962822
-
Cerebral magnetic resonance findings during enzyme replacement therapy in mucopolysaccharidosis.Pediatr Radiol. 2017 Nov;47(12):1659-1669. doi: 10.1007/s00247-017-3935-5. Epub 2017 Jul 21. Pediatr Radiol. 2017. PMID: 28733853
-
Neuroimaging Findings in Patients with Mucopolysaccharidosis: What You Really Need to Know.Radiographics. 2016 Sep-Oct;36(5):1448-62. doi: 10.1148/rg.2016150168. Radiographics. 2016. PMID: 27618324 Review.
-
Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management.J Inherit Metab Dis. 2011 Dec;34(6):1183-97. doi: 10.1007/s10545-011-9359-8. Epub 2011 Jul 9. J Inherit Metab Dis. 2011. PMID: 21744090 Free PMC article. Review.
References
-
- Prevalence of lysosomal storage disorders. Meikle PJ, Hopwood JJ, Clague AE, Carey WF. JAMA. 1999;281:249–254. - PubMed
-
- Overview of the mucopolysaccharidoses. Muenzer J. Rheumatology (Oxford) 2011;50:0–12. - PubMed
-
- Rheumatic heart disease. Marijon E, Mirabel M, Celermajer DS, Jouven X. Lancet. 2012;379:953–964. - PubMed
Publication types
LinkOut - more resources
Full Text Sources